Your browser doesn't support javascript.
loading
Characteristics, clinical significance, and cancer immune interactions of lipid metabolism in prostate cancer.
Xu, Zhipeng; Xu, Xu; Hu, Jianpeng; Tan, Jian; Wan, Yuanye; Cui, Feilun.
Afiliación
  • Xu Z; Department of Urology, Affiliated People's Hospital of Jiangsu University, The First People's Hospital of Zhenjiang, Zhenjiang, China.
  • Xu X; Department of Urology, Affiliated People's Hospital of Jiangsu University, The First People's Hospital of Zhenjiang, Zhenjiang, China.
  • Hu J; Department of Urology, Affiliated People's Hospital of Jiangsu University, The First People's Hospital of Zhenjiang, Zhenjiang, China.
  • Tan J; Department of Urology, Affiliated People's Hospital of Jiangsu University, The First People's Hospital of Zhenjiang, Zhenjiang, China.
  • Wan Y; Department of Urology, Affiliated People's Hospital of Jiangsu University, The First People's Hospital of Zhenjiang, Zhenjiang, China.
  • Cui F; Department of Urology, Affiliated Taizhou Second People's Hospital of Yangzhou University, Taizhou, China.
Transl Cancer Res ; 13(7): 3575-3588, 2024 Jul 31.
Article en En | MEDLINE | ID: mdl-39145061
ABSTRACT

Background:

The relationship between lipid metabolism, immune response, and immunotherapy in prostate cancer (PCa) is closely intertwined, and targeted intervention in lipid metabolism may facilitate the success of anticancer immunotherapy. This research attempted to explore effective immunotherapy for PCa.

Methods:

We obtained RNA sequencing (RNA-seq) data for PCa patients from the UCSC Xena platform. Data analysis of differentially expressed genes (DEGs) was performed using package limma in R. Then, DEGs were subjected to enrichment analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The Human Protein Atlas (HPA) database was conducted to validate the protein expression of the up-regulated lipid metabolism related genes (LMRGs) between PCa tissues and normal prostate tissues. And then we identified critical transcription factors (TFs), LMRGs and miRNA by constructing a regulatory network of TF-gene-miRNA. Furthermore, we determined the high and low groups based on the score of lipid metabolism enrichment. The hallmark gene sets were derived from gene expression profiles using the gene set variation analysis (GSVA) R package. Finally, we conducted immune infiltration analysis and drug sensitivity analysis.

Results:

Immune response and lipid metabolism have undergone significant changes in PCa and paracancerous tissues compared to normal tissues. A total of 21 LMRGs were differentially up-regulated in PCa. The TF-gene-miRNA network showed that PLA2G7, TWIST1, and TRIB3 may be the key genes that elevated lipid metabolism in PCa. The high group had more infiltration of B cell memory, macrophage M0, macrophage M1, and myeloid dendritic cell resting, and the low group had more infiltration of B cell plasma, monocyte, myeloid dendritic cell activated, and mast cell resting. The majority of checkpoint genes exhibited high expression levels in the low group. Lipid metabolism was remarkedly correlated with drug sensitivity.

Conclusions:

The analysis of lipid metabolism and related genes has revealed a complex regulatory mechanism that has a significant influence on immune response, immunotherapy, and medication guidance for patients with PCa. Keywords Prostate cancer (PCa); lipid metabolism; cancer immune; RNA sequencing (RNA-seq).

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Cancer Res Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Cancer Res Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: China